Tahani Boumenna

Tahani Boumenna has continuously pursued her passion for epidemiology and statistics, with a keen interest in investigating a number of disease patterns, identifying risk factors and public health outcomes. Her doctoral research consisted of investigating, cross-sectionally and longitudinally, risk factors associated with cognitive decline or dementia in older adults, specifically Boston-area Puerto Ricans. A study essential to the prevention of cognitive impairment in these populations.

Previously as Lead Epidemiologist at EMD Serono, she was pivotal leading and executing various epidemiological studies including regulatory studies related to pharmacovigilance. These studies provided critical insights into disease surveillance, rare disease prevalence, incidence worldwide, and intervention effectiveness. At Joslin Institute, she assisted researchers in the development of study objectives and provided the statistical analyzes outcomes related to various diseases such as eye disease, nephropathy and neuropathy. She also worked with glaucoma at MEEI/Channing Division of Network Medicine where she maintained disease follow-up from participants in nurses’ health studies and identified diagnostically different types of glaucoma cases such as Primary Open Angle-Glaucoma (POAG) and evaluating gene risk factors in relation to POAG.